公司資料
GeoVax Labs 股價、新聞與催化劑
- 股票代碼:
- GOVX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.66 USD (-8.77%)
收盤價
最後更新: 2026年8月17日
10.9M USD
市值
股價為何變動
As of Aug 17, 2026, GOVX closed down 8.77% at $0.6550. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
GeoVax Labs is a biotechnology company developing vaccines and immunotherapies using a virus-like particle platform. Its story is built around infectious disease and oncology programs that seek to create targeted immune responses.
所在地與產業分類
GeoVax is headquartered in the United States and listed on NASDAQ. It sits in small-cap vaccine and immunotherapy biotechnology.
商業模式特徵
The company depends on clinical and preclinical progress, partner interest, and capital efficiency to advance its platform. Investors watch vaccine updates, oncology programs, and whether the platform can produce differentiated immune responses.
生技產業定位
GeoVax occupies a niche vaccine-and-immunotherapy position within biotech. It is a catalyst-driven small-cap name where platform validation matters more than commercial scale.
未來催化劑
- GeoVax’s catalysts are vaccine and immunotherapy programs, plus any clinical or partnering step that keeps the platform relevant. The company still needs human proof.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。